Navigation Links
Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010
Date:2/10/2011

#160;Pain franchise sales of $540 - $570 million, oncology franchise sales of $570 - $600 million, and other product sales of $420 - $450 million remain unchanged. Full year R&D guidance is increased to $520 - $540 million and SG&A guidance remains unchanged at $970 million - $1.00 billion.  Adjusted net income guidance is increased to $665-$688 million.  Basic adjusted income per common share guidance is increased to $8.70 - $9.00, assuming 76.4 million basic shares outstanding.

Cephalon is introducing first quarter 2011 sales guidance of $725 - $755 million, adjusted net income guidance of $144 - $159 million and basic adjusted income per common share guidance of $1.90 - $2.10 assuming 75.8 million basic shares outstanding.  

Basic adjusted income per common share for both the first quarter 2011 and full-year 2011 is reconciled below and is subject to the assumptions set forth therein.  References in this press release to basic income per common share, basic adjusted income per common share, basic adjusted income per common share guidance, adjusted net income, adjusted net income guidance, adjusted net income per common share, adjusted net income per common share guidance refers to those metrics on an "attributable to Cephalon" basis and does not include any income or losses attributable to noncontrolling interests.

Cephalon's management will discuss the company's full year 2010 performance in a conference call with investors beginning at 5:00 p.m. U.S. EST today.  To participate in the conference call, dial +1-913-312-0724 and refer to conference code number 3115464. Investors can listen to the call live by logging on to the company's website at www.cephalon.com and clicking on "Investors" then "Webcast."  The conference call will be archived and available to investors for one week after the call.

About Cephalon, Inc.Cephalon is a global biopharmaceutical
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
2. ImmunGene Announces Multi-Target R&D Collaboration With Cephalon Australia for Interferon Payload Technology
3. Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
4. Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
5. Cephalon to Webcast Investor Day
6. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
7. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
8. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
9. Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
10. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
11. Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013 Hyland Software expands upon ... creating the Multi-Disciplinary Clinical Leadership Team. Led by ... experts with diverse healthcare experience, the team will ... create new software solutions that will enhance the ... patients and staff. Healthcare organizations use ...
(Date:5/20/2013)... Md. , May 20, 2013  Neuralstem, Inc. ... Feldman , MD, PhD, principal investigator, presented updated ... stem cell (NSI-566) trial in the treatment of amyotrophic ... ,s disease) at the neuro diabetes special medical symposium ... In a talk called "Recent Therapeutic Advances in Stem ...
(Date:5/19/2013)... Calif. , May 20, 2013 Claret Medical, ... Nicolas Van Mieghem et al., ... . Published ahead of print in Circulation, May 7 th ... Erasmus Medical Center, Rotterdam, the Netherlands ... of the Cardiovascular Pathology Institute, Gaithersburg, Maryland.  ...
Breaking Medicine Technology:Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2
... Group, Inc. recently published its TreatmentTrends®: Renal Anemia ... based on survey results from ... interviews conducted with ten thought leaders in nephrology.  The ... and focuses specifically on the management of renal anemia ...
... Research Group (MRG), the global authority on medical ... US cardiac resynchronization therapy defibrillator market will be ... chronic resynchronization therapy defibrillators in New York Heart ... The New York Heart Association classification system ranks ...
Cached Medicine Technology:New Report by BioTrends Examines the Treatment of Renal Anemia in China 2Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 2Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 3
(Date:5/20/2013)... Salt Lake Community College’s Know Greater Heroes program ... winners for 2013. As part of the award, the ... is a leadership training program that involves SLCC athletes who ... eat right, be active, and avoid drugs and alcohol. , ... program each year, and visit more than 30 schools each ...
(Date:5/20/2013)... May 20, 2013 Osborn’s Brain: ... to Anne G. Osborn’s 1993 award winning book Diagnostic ... the all-time bestselling neuroradiology texts. , In this ... touch to make complex topics visually appealing and easy ... brain imaging together with spectacular pathology examples, relevant anatomy, ...
(Date:5/20/2013)... 2013 Nearly 20 percent of kidneys that are ... for transplant due to factors ranging from scarring in ... the organ going too long without blood or oxygen. ... could be "recycled" to help solve the critical shortage ... Medical Center and colleagues, reporting in the journal ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 ... , Who:    Sloan Gibson, President, USO and ... President of Outreach Initiatives and Partners, ... Street , Representatives from:,              ...          • U.S. ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 ... adult allogeneic stem cell manufacturing, research and development, ... of Medicine and Director of Interventional Cardiology Research ... join the Scientific and Medical Advisory Board for ... of Pennsylvania, Dr. Wilensky divides his time between ...
Breaking Medicine News(10 mins):Health News:SLCC Know Greater Heroes Program Named to Select 25 2Health News:SLCC Know Greater Heroes Program Named to Select 25 3Health News:Osborn’s Brain from Amirsys Publishing Receives Doody’s Top Honors 2Health News:Study suggests new source of kidneys for transplant 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 2Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 3Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 4Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 2Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 3
... Inc (Seattle WA) has agreed to pay the US ... illegal marketing// of the anti-cancer prescription drug Trisenox, the ... ,According to the government's complaint, CTI promoted the drug ... Food & Drug Administration (FDA). ,The alleged ...
... ladders can result in serious injury and affect people of ... injuries, yet receives little// , if any, instruction on ladder ... in the May issue of the American Journal of Preventive ... Policy (CIRP) at Columbus Children’s Hospital, more than 2.1 million ...
... in 1150AD said about Asthma – , ... in mind is a rational conduct of life//." ... chronic disease which affects almost 300 million worldwide remains the ... most commonly discussed respiratory disease after the common cold. The ...
... a new agent, called "Zorro-LNA," which has the potential ... study, researchers from the Karolinska// Institute in Stockholm, Sweden, ... strands of a gene’s DNA simultaneously, effectively disabling that ... for virtually every human condition caused by or worsened ...
... the rise among kids in the US, according to the largest government ... ,Sugary foods and drinks and nonfluoridated bottled water may be ... ,An estimated 28 percent of U.S. children ages 2 to 5 had ... This compared to a 24 percent rate from 1988 to 1994. ...
... cases of Polio reported globally are 111 out of which 31 ... number of polio cases reported// during the last three years, State ... circulation of wild polio virus following action are being taken: ... 2007 ,? One SNID implemented in UP, Bihar and ...
Cached Medicine News:Health News:CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG 2Health News:Ladder-related Injuries on the Rise in U.S 2Health News:Asthma can Be Checked, Experts are Confident 2Health News:Asthma can Be Checked, Experts are Confident 3Health News:Asthma can Be Checked, Experts are Confident 4Health News:New Agent to Fight Genetic Disorders Found 2Health News:Sugary Foods Turn Kids Teeth Rotten in US 2Health News:Polio Cases In The Country 2
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
DP 2020 Series 3-chip cameras offer the user unparalleled clarity and definition. Chroma dynamic range is extended and red colour reproduction is superb....
Medicine Products: